CYP17 inhibitor (Target Medicals)

N/A

Report date: 2025/03/19 11:39:16
NME

Base Information

Drug NameCYP17 inhibitor (Target Medicals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSteroid 17-alpha-hydroxylase inhibitors
TargetsSteroid 17-alpha-hydroxylase
Therapy Area/IndicationsProstatic NeoplasmsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTarget Medicals LLC
China Registration ClassN/A

Develop Information

Active CompaniesTarget Medicals LLC
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A